ExLibris header image
SFX Logo
Title: Panel urges wide use of antiviral drug
Source:

Science [0036-8075] T. H. Maugh, 2nd yr:1979


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Richman, D. "Antiviral drug resistance." Antiviral research 71.2-3 (2006): 117-121. Link to SFX for this item
2. Collier, L. H H. HUMAN VIROLOGY: A TEXT FOR STUDENTS OF MEDICINE, DENTISTRY, AND MICROBIOLOGY. 2006. Link to SFX for this item
3. Little, S. "HIV treatment decisions and transmitted drug resistance." Clinical infectious diseases 41.2 (2005): 233-235. Link to SFX for this item
4. Vivet-Boudou, V. "Nucleoside and nucleotide inhibitors of HIV-1 replication." Cellular and molecular life sciences 63.2 (2006): 163-186. Link to Full Text for this item Link to SFX for this item
5. W, D. "Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection." Proceedings of the National Academy of Sciences of the United States of America 102.51 (2005): 18514-18519. Link to Full Text for this item Link to SFX for this item
6. Bartlett, John A A. "Minimizing resistance consequences after virologic failure on initial combination therapy: A systematic overview." Journal of acquired immune deficiency syndromes 41.3 (2006): 323-31. Link to SFX for this item
7. Norkin, Leonard C. "A mutation in the receptor binding site enhances infectivity of 2009 H1N1 influenza hemagglutinin pseudotypes without changing antigenicity." Virology : molecular biology and pathogenesis. 2010. 2231-2295. Link to SFX for this item
8. Nikitina, I. "Absence of genotypic drug resistance and presence of several naturally occurring polymorphisms of human immunodeficiency virus-1 CRF06_cpx in treatment-naive patients in Estonia." Journal of medical virology 81.6 (2009): 953-8. Link to Full Text for this item Link to SFX for this item
9. Mahy, A. Dictionary of Virology. 2001. Link to SFX for this item
10. Blum, Ronald A A. "HIV resistance testing in the USA - a model for the application of parmacogenomics in the clinical setting." Pharmacogenomics 6.2 (2005): 169-179. Link to SFX for this item
11. Jaafar, A. "HIV therapy after treatment interruption in patients with multiple failure and more than 200 CD4+ T lymphocyte count." Journal of medical virology 74.1 (2004): 8-15. Link to Full Text for this item Link to SFX for this item
12. Pérez-Alvarez, L. "Long-term monitoring of genotypic and phenotypic resistance to T20 in treated patients infected with HIV-1." Journal of medical virology 78.2: 141-147. Link to SFX for this item
13. Haraguchi, Y. "Evolutionary pattern of intra-host pathogen antigenic drift: Effect of cross-reactivity in immune response." Philosophical transactions of the Royal Society of London 352.1349 (1997): 11-20. Link to SFX for this item
14. Esnouf, D. "Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors." Nature structural biology 2.4 (1995): 303-8. Link to Full Text for this item Link to SFX for this item
15. Poon, Art F Y F. "Evolutionary Interactions between N-Linked Glycosylation Sites in the HIV-1 Envelope." PLoS Computational Biology 3.1 (2006): -119. Link to Full Text for this item Link to SFX for this item
16. Gallant, J. "Early virologic nonresponse to tenofovir, abacavir, and lamivudine in HIV-infected antiretroviral-naive subjects." The journal of infectious diseases 192.11 (2005): 1921-1930. Link to Full Text for this item Link to SFX for this item
17. Nettles, RE E. "Intermittent HIV-1 viremia (blips) and drug resistance in patients receiving HAART." JAMA 293.7 (2005): 817-829. Link to SFX for this item
18. Kunkel, T A A. "DNA replication fidelity." Annual review of biochemistry 69.1 (2000): 497-529. Link to Full Text for this item Link to SFX for this item
19. Kantor, R. "Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration." PLoS medicine 2.4 (2005): 325-337. Link to Full Text for this item Link to SFX for this item
20. Herschhorn, A. "Mechanism of inhibition of HIV-1 reverse transcriptase by the novel broad-range DNA polymerase inhibitor N-{2-[4-(aminosulfonyl)phenyl]ethyl}-2-(2-thienyl)acetamide." Biochemistry 47.1 (2008): 490-502. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.